New funding will support development of LambdaVision's implant aimed to cure vision impairment and blindness(PRWeb October 16, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14794069.htm
LambdaVision is a Connecticut-based biotechnology company that develops and commercializes protein-based retinal implants for the treatment of retinal degenerative diseases.